Company Valuation: Biostax Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Market Cap 1 1.954 2.974 6.835 1.441 49.83 6.11
Change - 52.18% 129.81% -78.92% 3,358.09% -87.74%
Enterprise Value (EV) 1 7.136 8.515 9.67 2.088 50.37 7.264
Change - 19.31% 13.57% -78.41% 2,312.7% -85.58%
P/E -0.24x -0.88x 4.35x 7.87x -6x -3.65x
PBR -0.17x -0.22x -0.59x -0.18x -19.8x -1.6x
PEG - 0x -0x -0.1x 0x 0x
Capitalization / Revenue 17.2x - - - - -
EV / Revenue 62.9x - - - - -
EV / EBITDA -1.75x -3x -10.9x -2.83x - -5.08x
EV / EBIT -1.75x -3x -10.9x -2.83x -43.3x -4.89x
EV / FCF -3.3x 84.8x -83x -1x -8.65x -20.3x
FCF Yield -30.3% 1.18% -1.2% -100% -11.6% -4.93%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -19.03 -7.423 3.334 0.38 -0.1 -0.02
Distribution rate - - - - - -
Net sales 1 0.1135 - - - - -
EBITDA 1 -4.083 -2.836 -0.8864 -0.7375 - -1.431
EBIT 1 -4.085 -2.838 -0.887 -0.7382 -1.163 -1.485
Net income 1 -8.175 -3.397 1.589 3.586 -3.536 -1.651
Net Debt 1 5.182 5.54 2.835 0.647 0.546 1.154
Reference price 2 4.500000 6.500000 14.510000 2.990000 0.600000 0.073035
Nbr of stocks (in thousands) 434 458 471 482 83,046 83,658
Announcement Date 4/16/19 5/14/20 4/15/21 3/18/22 4/10/23 4/16/24
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 21.65K
17.13x6.55x12.55x1.74% 65.56B
32.67x8.73x28.87x0.07% 60.41B
38.83x6.91x20.67x0.84% 55.76B
44.13x6.17x29.36x-.--% 46.98B
34.55x3.29x14.19x-.--% 43.63B
36.23x8.96x23.37x0.36% 36.7B
-19.98x53.61x-21.71x-.--% 36.09B
41.91x8.08x27.1x-.--% 32.9B
-74.98x14.21x-76.38x-.--% 26.96B
Average 16.72x 12.95x 6.45x 0.33% 40B
Weighted average by Cap. 21.75x 11.58x 11.42x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Biostax Corp.

Historical PBR trend

Valuation ratios - PBR - Biostax Corp.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Biostax Corp.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Biostax Corp.

  1. Stock Market
  2. Stocks
  3. BTAX Stock
  4. Valuation Biostax Corp.